Skip to main content

Quality of Life

Fear and Lack of Confidence Negatively Impact Control1

 

A significant number of people with diabetes suffer from fear of hypoglycemia. This not only can worsen control and complication risk, but it can also lead to increased anxiety.

 

Eversense Users Report Increased Motivation, Confidence and Control

Participants in the PRECISE clinical trial reported improvements on all domains of the Diabetes Distress Scale (DDS) and an increased sense of safety, confidence and reduced emotional burden.2

 
  • 86% reported that it minimized the burden of diabetes.
  • 85% reported improved confidence over their diabetes control.
  • 80% were more motivated to keep up with diabetes management.
 
Sensor

OVERWHELMING MAJORITY OF EVERSENSE USERS FEEL OPTIMISTIC AND SAFE

 

A LIFESTYLE FRIENDLY DESIGN THAT IMPROVES WEAR TIME AND CONFIDENCE

 
  • Enhanced psychosocial outcomes are linked to duration of CGM use.3,4
  • The first and only long-term CGM system that lasts up to 180 days.
  • Implantable sensor eliminates self-insertions and site maintenance.
  • Silicone-based, hypoallergenic adhesive has shown no irritation or reactions.5*

To find out more about improvements in emotional burden and Quality of Life measures, contact us to get a copy of our white paper and patient case study.

1 Polonsky WH. Diabetes Technology & Therapeutics. Volume 19, Number 1, 2017 2 Barnard KD. J Diabetes Sci Technol. 2018;12(3):634-638. 3 Tansey M. Diabetic Medicine, Volume28, Issue9, September 2011, Pages 1118-1122. 4 Kubiak T. Journal of Diabetes Science and Technology. 2016, Vol. 10(4) 859–863. 5 Christiansen MP. PRECISE II. Diabetes Technology & Therapeutics. 2018;20(3):197-206.
* Over 9,773 sensor wear days

MKT-001294 Rev1